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ABSTRACT
The results of modern research on the creation of pharmacologically active bandage were generalized. The main components of the development of 
pharmacologically active dressing (choice of active ingredients, carrier substrate, the method of immobilization, etc.) were determined. Methodological 
approaches to the creation of pharmacologically active bandage were developed. The practical significance of the developed methodological 
approaches was demonstrated by research and development of dressings with thick oak bark extract.
Keywords: Pharmacologically active bandage, Methods of immobilization, Plaster, Medical pad, Thick oak bark extract.
INTRODUCTION
Traditional medicines in the form of such dosage forms as ointments, 
creams, gels, pastes, liniments, tinctures, foam, powder, etc., can be used 
for topical application of various lesions.
Years of research in biopharmaceutics demonstrate a constant search for 
improving and new ways for delivery of already known medicines. With 
the development of scientific and technological progress and increasing 
pace of life, an important area of research is developing drugs for local 
therapy in dosage forms ensuring maximum convenience and eases of 
use, have high consumer quality, have directed pharmacological action. 
Such requirements are met by dosage forms intended for applying 
to the surface of the skin or mucous membranes - plasters, wipes 
bandages, etc.
These dosage forms are traditional while manufacturing 
bandaging - medical products made of one or several bandages and 
intended for the prevention and treatment of infected wounds, burns 
and other skin, tissue and mucous membranes damage [1-4].
Transdermal therapeutic systems with hormonal, cardiological, cancer, 
and other preparations are also produced in the form of plaster. It is a 
complex, efficient way to deliver drugs that require detailed study and 
prediction of pharmacokinetic parameters, so their development and 
production are quite long and have high cost [5-8].
Nowadays, the concept of pharmacologically active bandage (PhAB) 
includes a traditional woven and non-woven materials, dressing, 
film, sponge, hydrocolloids, powders, pastes, and combined 
materials [2,3,9,10].
According to modern requirements of medicine and pharmacy, 
the wound closure materials market is developing rapidly. Besides 
traditional wound closure materials, the range of innovative bandages 
and wound closure is gradually expanding, including biologically 
active materials based on alginic acid, which, while contacting with 
exudate, turns into gel, osmotically active bandages that remove 
necrotic tissues from a wound, adsorbing bandages with activated 
carbon that can remove foul smell, and other innovative products. 
However, according to the studies, currently, their range is not wide 
enough.
The range of wound closure materials in Ukraine is represented by 
gossypium (11.67%), gauze fabric (10.34%), drapes (5.84%), various 
bandages (19.09%) and plasters (36.88%), compresses (1.33%), 
bandaging packs (1.59%), and bands (13.26%) [11].
The functions of wound closure materials are protection from the 
external environment (traumatic factors, excessive moisture or 
drying, dust, dirt, desquamated epithelium), prevention of wound 
contamination by microorganisms, removal of tissue decay products, 
microorganisms, toxins, enzymes, therapeutic effect (antimicrobial, 
hemostatic, analgesic, regenerating, immunostimulatory, etc.), and 
fixation of drug on a wound [12-14].
According to this, turner has formulated the criteria for the so-
called “ideal bandaging:” (1) removing exudate; (2) creating 
moist environment; (3) ability for gas exchange; (4) maintaining 
temperature control; (5) preventing infection; (6) non-toxic; (7) non-
invasiveness [3,14-16].
With the development of science and technology, there appeared 
such additional requirements as active effect on wound process by 
introducing medicinal agent, possibility of contactless visual control 
over the wound, resistance to sterilization, ease of use, duration of use 
on wounds, etc. [3,15].
The task of bandaging varies in each phase of wound healing. In the 
inflammation phase, there can be used both wet and dry bandages 
that are designed to remove excess exudate with bacteria, toxins, 
detritus, debrides, and keep them with the structure of a bandage; 
stimulate rehydration and accelerate necrolysis; protect against 
recontamination [10,14,17]. In the granulation phase, non-invasive 
hydroactive bandages are preferred that maintain moist environment 
(absorb excess secret, prevent drying of the wound and if necessary 
provide it with measured dosage of moisture); condition wounds; 
protect from mechanical damage and secondary infection. The task 
of the epithelialization phase is maintaining moist environment; 
protecting epithelium and open sword cut from mechanical damage 
during bandaging; stimulating regeneration [10,13].
The aim of this article is to identify the main components of the 
development process of pharmacologically active bandage (PhAB) and 
develop a methodological approach to create them.
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The vast majority of pharmacologically active patches and dressings 
on the Ukrainian market refer to medical products; therefore, the 
development and production of PhAB need to meet the requirements of 
the corresponding standard documentation.
In Ukraine, Technical Regulations on Medical Products (Decree 
dated: 11.06.2008 №. 256) have been valid since 2008, that define 
general requirements to a product (including bandage), its safety 
and conformity procedures. According to the Ukrainian legislation, 
transdermal plasters, and PhAB belong to drugs and must meet the 
general requirements for drugs.
In the development and implementation of PhAB for high-quality 
products certain requirements must be met [1,3,15,18] to:
• The choice of materials, in particular regarding their toxicity and 
safety;
• The compatibility of the materials with the tissues, cells, and body 
fluids of the human body taking into account the purpose of the 
product;
• Effect on human tissue, duration, and frequency of the application;
• Elimination or maximum reduction of the risk of a patient, user, or 
another person;
• Packing of non-sterile and sterile medical products.
PhAB may have a local effect on the surface of the skin or mucous 
membranes, and the overall effect on the body as a whole.
To develop, PhAB for local application depending on the goal of 
research, anti-inflammatory, antibacterial, antifungal, local anesthetic, 
antihistamines, and some other media can be selected as the active 
substance.
PhAB can be made in two ways - without using media and by applying 
composition of some active substance (as a solution, emulsion, 
suspension, gel, etc.) to a specific media (woven or non-woven material, 
film, etc.).
PhAB made without media are represented by synthetic (polylactide, 
polyvinyl, etc.) and polysaccharide coatings, such as a water-soluble 
derivative of cellulose, chitosan, calcium, and/or sodium alginate, made 
in the form of hydrophilic fibrous nonwoven material; alginate, collagen 
and chitinous sponges, films, and membranes [19-22].
The following application materials are biodegradable and completely 
dissipate on a wound. However, the appropriateness of their use in the 
treatment of wound healing process is a matter of scientific discussions, 
since the products of degradation of such bandage remain in the wound 
without being removed [23-26].
The second method involves the immobilization of active substance 
on a specific media and is based on physical (electrostatic, dispersion, 
and hydrophobic) and/or chemical interactions of biologically active 
substances with the media. The immobilization methods can be 
divided into physical, chemical, and combined. The choice of method of 
immobilization largely depends on physical-chemical properties of the 
active substance [1,3].
The simplest methods of physical immobilization of drugs on the media 
are adsorption from the saturated composition by dipping material 
in solution and applying saturated composition in the form of gel, 
powder, and paste on the surface of the media. These methods are the 
easiest in implementation and economically most beneficial, but their 
disadvantage is quite weak retention of the components of saturated 
composition on the media surface [1,2,27].
A kind of physical immobilization is the printing method, which 
involves the introducing biologically active substances in saturated 
polymer composition (e.g., based on polysaccharides), and applying it 
on textile material.
For applying the composition, traditional technologies can be used 
that are employed while processing of fabrics - printed through a 
mesh pattern. This method of PhAB production ensures their long 
pharmacological effect in operational process and makes it possible to 
achieve sufficiently high concentrations of drugs on media. Virtually all 
drugs can be introduced into a polymer composition, including those 
insoluble in the components of a composition. The disadvantage of this 
method is the complexity of the process hardware [1,2,3,15].
The chemical immobilization methods include joining biologically active 
substance to the media with a chemical bond. This method is the most 
time-consuming, technically complicated method of immobilization. 
Mass transfer of the drug from the textile material into the environment 
is conducted providing further hydrolytic degradation of linking between 
functional groups of partners, involved in the reaction. Active substance 
has to be specially prepared (chemically modified), and its linking with 
the media must be both robust enough and labile. The formation of 
different types of chemical bonds when creating immobilized agents 
depends, on the one hand, on the reactive capable fiber groups and, on 
the other hand, on the presence of such groups in preparation.
Due to the complexity and high cost, the chemical immobilization 
methods have not been properly developed yet. They may be justified 
in case of effective, unique drugs used in low concentrations, e.g., for the 
immobilization of enzymes.
Immobilization on the media could also be achieved by combining 
physical and chemical methods, such as including biologically active 
substances into the solution for making fiber for further manufacturing 
of textile material with specific therapeutic properties [27,28].
One of the parameters that affect the quality of PhAB is the choice 
of media. The choice is made among the materials permitted for 
application in medicine, taking into account medical, biological, and 
technological requirements to the material. The media must be resistant 
to chemical and microbial biodegrade have high mechanical resistance, 
possess minimum non-specific adsorption, be able to conjugate with 
active components and not inhibit the action of the active substance, 
should not cause mechanical or chemical irritation or have cytotoxic 
and sensitization influence [1,2,27].
Depending on the purpose and place of applying the product, there are 
different requirements for mechanical properties of material. Providing 
it is applied to a wound, ulcer, or burnt surface, untraumatic thin 
material is preferred.
When used on the surface of the body that involves frequent bandage 
deformation (e.g., limbs, elbow joints), an important aspect of choosing 
material is studying its bursting properties when wet [12-15]. 
Depending on the type and structure of material, the bursting stress 
value varies significantly.
An important requirement to the media of bandage is possibility 
of oxygen and carbon dioxide exchange and humidity regulating. 
Permeability for gasses and moisture depends on the structure 
and nature of the material and is listed by the manufacturer in the 
legal requirements for the product. Textiles, such as gauze, non-
woven material, have higher permeability than products of synthetic 
materials (e.g., hydrogel or hydrocolloid bandages with their occlusal 
properties) [1-3,15,27].
In developing bandaging for treating inflammatory lesions at the stage of 
selecting media, hygroscopic characteristics of the material - capillarity, 
wetting speed - should be considered.
Capillarity criterion is the ability of material to absorb effectively 
exudate and purulent discharge and drain the wound and is determined 
by the height of colored liquid lifting (e.g., a solution of potassium 
dichromate R) along a vertically fixed sample material for 1 hour. 
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Capillarity index of <100 mm/h characterizes low capacity of a bandage 
to clean the wound [1-3].
The modern materials used as media for bandaging may be of natural or 
synthetic origin, be inert or possess its activity.
Among natural organic media cellulose as gauze and other materials 
(methylcellulose, carboxymethylcellulose, bromoacetylcellulose, 
microcrystalline cellulose, etc.), textiles, collagen, starch, dextrin 
(sephadex), agar (sepharose), glycogen, and chitin and their derivatives, 
whose activity is caused by a chain structure of macromolecules and 
ability of hydrophilic functional groups to bind tightly molecules of 
water environment and organic components of exudate and form a 
spatial cross-linking (grids) are used.
Synthetic organic media are represented by acrylate polymers 
(acrylamide), ion exchange resins, nylon, polyvinyl alcohol, 
polyurethane, polyoxyether, organometallic polymers, etc.
Materials based on natural compounds are usually well compatible 
with body tissues. In contrast, synthetic polymers contain a number 
of chemically reactive monomers and products of their reactions and 
polymerization catalysts, which increases the risk of local irritant 
action [1-3,29-32].
The range of media for producing bandaging widens at the expense 
of polymers that have smooth surface, are easy and noninvasively 
removed, and do not slow down regenerative processes. Some polymer 
films already contain antiseptic and hemostatic drugs. Polymeric 
perforated film, film bandage with polyvinyl chloride, etc., are produced. 
All these materials have the advantage – noninvasiveness but have 
worse drainage properties compared to cotton-gauze and non-woven 
material.
To ensure a therapeutic effect of pharmacologically active bandaging, 
one of the most important aspects is explaining the choice of auxiliary 
substances (solvents, polymers, etc.).
To the solvents used to prepare saturated solutions, the following 
requirements are set [1,3,32]:
• Storage stability;
• Instant sufficient capacity;
Fig. 1: Methodological approaches of development of the PhAB
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• Minimal risk of side effects.
When choosing a solvent, the possibility of interaction with other 
components of the solution and the impact on the adsorption processes 
that can significantly affect bioavailability must be considered.
Providing a medicinal product is applied as a part of polymer 
composition, choosing the polymer, which directly affects the speed 
and completeness of drug release is an important step of the research.
For this purpose, synthetic and natural substances - polyvinyl 
alcohol, alginates, collagen, chitosan, cellulose, gelatin, etc., - are 
used [15,17,21,33-36].
To justify, the choice and concentration of the polymer when creating 
saturated solutions, it is advisable to study the rheological parameters 
of the compositions (thixotropy, viscosity, etc.). For each polymer 
substance, there should be experimentally set the optimal concentration 
that will provide strength and structuring of the composition necessary 
for the process. The viscosity required for the saturating solution 
depends on the method of application and equipment, which is used 
and is determined experimentally.
One of the main factors that can significantly influence therapeutic 
effect of bandaging is the concentration of active ingredients in it. 
Biopharmaceutical studies show that for every substance of the 
optimum concentration may be determined beyond which its increase 
will not lead to a significant increase in its pharmacological activity. 
The optimum concentration of drug in the product should be clearly 
justified basing on pharmacological or microbiological research.
To prevent, the growth of microbial contamination during storage or 
use, medicinal products must have an effective preservative effect. 
Microbiological purity of drugs is provided either by introducing 
antimicrobial preservatives or due to preserving antimicrobial activity 
of active substances and appropriate conditions of production.
Bandaging does not have such stringent requirements, but in the case 
of a large wound surface, further contamination of the wound is not 
very desirable.
The research of biopharmaceutical, pharmacological, and toxicological 
characteristics of the developed bandaging is the final stage of research 
and allows to evaluate therapeutic and consumer product quality.
RESULTS AND DISCUSSION
Based on the foregoing, we have formulated methodological approaches 
to creating PhAB in the process of development, which are the following 
stages (Fig. 1).
We have used this approach in the development of PhAB based on thick 
oak bark extract - plaster and napkins [37,38].
An integrated approach to developing new PhAB using modern 
scientific methods allows getting highly efficient products that meet the 
requirements of medicine and pharmacy in the rapid development of 
science and technology.
CONCLUSIONS
1. The results of current research on developing pharmacologically 
active bandaging are generalized.
2. The main components of the process of developing pharmacologically 
active bandaging (choice of active substances, media, the method of 
immobilization, etc.) are defined.
3. Methodological approaches to developing pharmacologically 
active bandaging using modern scientific methods of research are 
developed.
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